Sargent Bickham Lagudis LLC Novartis Ag Transaction History

Sargent Bickham Lagudis LLC

$1.22 Billion
Q4 2022

A detailed history of Sargent Bickham Lagudis LLC transactions in Novartis Ag stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 2,537 shares of NVS stock, worth $293,404. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,537

Previous 3,926 35.38%

Holding current value

$293,404

Previous $298,000 22.82%

% of portfolio

0.02%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$75.55 - $92.52 $104,938 - $128,510	-1,389 Reduced 35.38%	2,537 $0
Q3 2022 Oct 27, 2022	SELL	$74.61 - $87.26 $35,887 - $41,972	-481 Reduced 10.91%	3,926 $298,000
Q2 2022 Jul 13, 2022	SELL	$80.52 - $93.75 $10,467 - $12,187	-130 Reduced 2.87%	4,407 $373,000
Q1 2022 Apr 27, 2022	BUY	$80.11 - $90.62 $7,209 - $8,155	90 Added 2.02%	4,537 $398,000
Q4 2021 Jan 18, 2022	SELL	$79.7 - $88.13 $9,803 - $10,839	-123 Reduced 2.69%	4,447 $389,000
Q3 2021 Nov 05, 2021	BUY	$81.78 - $95.14 $124,714 - $145,088	1,525 Added 50.08%	4,570 $374,000
Q2 2021 Jul 19, 2021	BUY	$85.24 - $94.15 $101,776 - $112,415	1,194 Added 64.51%	3,045 $278,000
Q1 2021 May 24, 2021	BUY	$83.5 - $98.47 $134,184 - $158,241	1,607 Added 658.61%	1,851 $158,000
Q4 2020 May 24, 2021	SELL	$78.07 - $94.43 $125,458 - $151,749	-1,607 Reduced 86.82%	244 $23,000
Q4 2020 May 24, 2021	BUY	$78.07 - $94.43 $125,458 - $151,749	1,607 Added 658.61%	1,851 $158,000
Q1 2020 Sep 07, 2021	SELL	$70.67 - $99.01 $4,593 - $6,435	-65 Reduced 21.04%	244 $20,000
Q4 2019 Sep 14, 2021	BUY	$84.35 - $95.37 $5,229 - $5,912	62 Added 25.1%	309 $29,000
Q1 2019 Sep 13, 2021	SELL	$75.32 - $86.15 $22,595 - $25,845	-300 Reduced 54.84%	247 $24,000
Q4 2018 Sep 13, 2021	SELL	$73.66 - $82.02 $28,727 - $31,987	-390 Reduced 41.62%	547 $47,000
Q3 2018 Sep 13, 2021	SELL	$66.94 - $77.43 $4,418 - $5,110	-66 Reduced 6.58%	937 $81,000
Q2 2018 Sep 13, 2021	SELL	$64.91 - $73.36 $59,392 - $67,124	-915 Reduced 47.71%	1,003 $76,000
Q1 2018 Sep 13, 2021	SELL	$70.39 - $84.15 $54,693 - $65,384	-777 Reduced 28.83%	1,918 $155,000
Q4 2017 Sep 13, 2021	SELL	$72.33 - $77.64 $42,964 - $46,118	-594 Reduced 18.06%	2,695 $226,000
Q3 2017 Sep 13, 2021	BUY	$74.14 - $77.27 $25,059 - $26,117	338 Added 11.45%	3,289 $282,000
Q2 2017 Sep 13, 2021	SELL	N/A	-2 Reduced 0.07%	2,951 $246,000
Q1 2017 Sep 13, 2021	SELL	N/A	-458 Reduced 13.43%	2,953 $219,000
Q4 2016 Sep 13, 2021	SELL	N/A	-321 Reduced 8.6%	3,411 $248,000
Q3 2016 Sep 13, 2021	BUY	N/A	443 Added 13.47%	3,732 $295,000
Q2 2016 Sep 07, 2021	BUY	N/A	757 Added 29.9%	3,289 $271,000
Q1 2016 Sep 07, 2021	BUY	N/A	2,532	2,532 $183,000

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Account

Sargent Bickham Lagudis LLC Novartis Ag Transaction History